Functional Profiling of In Vitro Reactivated Memory B Cells Following Natural SARS-CoV-2 Infection and Gam-COVID-Vac Vaccination자연 SARS-CoV-2 감염 및 Gam-COVID-Vac 백신 접종 후 시험관 내 재활성화된 기억 B 세포의 기능 프로파일링Article Published on 2022-06-212022-09-11 Journal: Cells [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] Adenovirus antibody antibody-secreting cells B-cell response circulating comprehensive analysis convalescent patient Convalescent patients COVID-19 COVID-19 convalescent patient COVID-19 convalescent patients demonstrated elicit frequencies Frequency Gam-COVID-Vac Gam-COVID-Vac vaccine healthcare humoral Humoral immunity immune response immune responses Immunity individual Infection MBC MBCs memory B memory B cell memory B cells natural natural immunity Neutralizing Neutralizing antibodies outperform performed platform Profiling Receptor binding domain recipients robust SARS-CoV-2 SARS-COV-2 infection Serum level serum levels side significantly higher Sputnik V vaccine vaccination variants of SARS-CoV-2 Viral viral antigens virus-neutralizing virus-neutralizing antibodies [DOI] 10.3390/cells11131991 PMC 바로가기 [Article Type] Article
Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2SARS-CoV-2에 대한 자연 및 하이브리드 면역의 보호 및 약화Article Published on 2022-06-092022-09-11 Journal: The New England Journal of Medicine [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 adjusted B.1.617.2 BNT162b2 BNT162b2 vaccine confounding factor confounding factors coronavirus Coronavirus 2019 Course database dose elapsed hybrid Immunity infected with SARS-CoV-2 Infection less Ministry of Health natural natural immunity Poisson regression predominant protection provide provided rates of infection receipt recent Reinfection risk SARS-CoV-2 SARS-COV-2 infection second dose second dose of vaccine severe acute respiratory syndrome Coronavirus shown single dose uninfected vaccination Vaccine variant [DOI] 10.1056/NEJMoa2118946 PMC 바로가기 [Article Type] Article
HLA variation and antigen presentation in COVID-19 and SARS-CoV-2 infectionCOVID-19 및 SARS-CoV-2 감염에서 HLA 변이 및 항원 제시Review Published on 2022-06-012022-09-11 Journal: Current opinion in immunology [Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘, [키워드] Affect affinity Antigen Antigen presentation association COVID-19 Critical Genotype HLA HLA molecules HLA variation human leukocyte antigen immune evasion immune response immune responses Immunity immunogenic leukocyte mechanism mutant Mutation natural immunity outcome peptide peptides prediction Protein SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 proteins shown Spike protein strain T cells T-cell Response T-cell responses the Spike understanding Vaccine development variant Variation viral strains [DOI] 10.1016/j.coi.2022.102178 PMC 바로가기 [Article Type] Review
SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunitySARS-CoV-2 재감염: 자연 면역 및 잡종 면역의 효능 및 기간 개요Review Published on 2022-06-012022-09-11 Journal: Environmental research [Category] COVID19(2023년), SARS, 변종, [키워드] Combination death dose effect size Efficacy epidemiological studies Epidemiological study Final greater Health policy Hospitalization hospitalizations hybrid Hybrid immunity Immunity individual infected with SARS-CoV-2 infections knowledge moderate mRNA vaccine natural natural immunity observational studies observational study offer omicron Omicron variant provide public health receiving reduced reduced risk Reinfection Reinfections SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 variants Seroprevalence severe disease significantly vaccination Vaccines variant waning immunity [DOI] 10.1016/j.envres.2022.112911 PMC 바로가기 [Article Type] Review
Risk of SARS-CoV-2 Reinfection 18 Months After Primary Infection: Population-Level Observational Study1차 감염 18개월 후 SARS-CoV-2 재감염 위험: 인구 수준 관찰 연구Observational Study Published on 2022-05-022022-09-11 Journal: Frontiers in Public Health [Category] COVID19(2023년), SARS, 변종, 임상, [키워드] Analysis average Cohort cohort study COVID-19 current deaths eight females Hospitalization incidence Italian Italy Month natural immunity omicron Omicron variant pandemic Primary infection recorded reduce Reinfection retrospective cohort risk SARS-CoV-2 significantly higher subject subjects Uncertainty vaccination variant [DOI] 10.3389/fpubh.2022.884121 PMC 바로가기 [Article Type] Observational Study
Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort studyArticle Published on 2022-05-012022-11-16 Journal: The Lancet. Healthy longevity [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI age Alpha Analysis appear B.1.1.529 booster vaccination Care cohort study Course Coverage datasets death Department diagnosed disease severity eligible England excluded finding for inclusion hazard ratio Hospital admission indicated Infection investigated IQR Lateral flow device male median age MONITOR Mortality National National Health Service natural immunity NHS Observed Omicron variant outcome participant PCR Population positive positive PCR prospective cohort study PROTECT public health reduced reduction in resident risk risk of death SARS-CoV-2 SARS-CoV-2 test Sequencing severe disease severity Sex study period subset Surveillance tested unlikely Vaccine variant variants [DOI] 10.1016/S2666-7568(22)00093-9 PMC 바로가기
An Observational Cohort Study on the Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and B.1.1.7 Variant Infection in Healthcare Workers by Antibody and Vaccination Status중증급성호흡기증후군 코로나바이러스 2(SARS-CoV-2) 감염 및 B.1.1.7 항체 및 백신 접종 상태에 따른 의료 종사자의 변이 감염 발생률에 대한 관찰 코호트 연구Observational Study Published on 2022-04-092022-09-11 Journal: Clinical Infectious Diseases: An Official Publicat [Category] COVID19(2023년), SARS, 변종, 임상, 치료기술, 치료제, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 adjusted age anti-spike antibodies anti-spike antibody antibody B.1.1.7 B.1.1.7 variant BNT162b2 ChAdOx1 ChAdOx1 nCoV-19 Chain Reaction changes in confidence interval coronavirus coronavirus 2 detectable dose doses evade Evidence evidence of HCW HCWs healthcare healthcare worker Healthcare workers Immunity incidence incidence rate Infection investigated longitudinal cohort study natural natural immunity natural infection no evidence of Oxford-AstraZeneca pandemic PCR-positive Pfizer-BioNTech Poisson regression polymerase chain polymerase chain reaction provided rate ratio reduced respiratory resulting robust S-gene SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant SARS-CoV-2 variants Sequencing seronegative seropositive Seropositivity severe acute respiratory syndrome Coronavirus Sex Single-dose status symptomatic symptomatic and asymptomatic symptomatic infection United Kingdom vaccination Vaccine vaccine dose Vaccine-induced immunity whole genome Whole genome sequencing without symptom worker [DOI] 10.1093/cid/ciab608 PMC 바로가기 [Article Type] Observational Study
What Is the Antibody Response and Role in Conferring Natural Immunity After SARS-CoV-2 Infection? Rapid, Living Practice Points From the American College of Physicians (Version 2)SARS-CoV-2 감염 후 자연 면역을 부여하는 항체 반응과 역할은 무엇입니까? American College of Physicians(버전 2)의 신속하고 생생한 실습 포인트Article Published on 2022-04-012022-09-11 Journal: Annals of internal medicine [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] agency antibody Antibody Response antibody tests best cellular immunity college Committee conducted diagnosis of SARS-CoV-2 effective vaccine Effective vaccines evaluate Evidence foundation Immunity Infection natural natural immunity physician Point Policy Practice predict Prevalence preventing infection Quality Rapid recommendation Reinfection response retirement role SARS-CoV-2 SARS-CoV-2 antibody test SARS-CoV-2 antibody tests SARS-COV-2 infection systematic review the antibody response Topic vaccination variants Version widespread [DOI] 10.7326/M21-3272 PMC 바로가기 [Article Type] Article
Can the SARS-CoV-2 Omicron Variant Confer Natural Immunity against COVID-19?SARS-CoV-2 오미크론 변이체가 COVID-19에 대한 자연 면역을 부여할 수 있습니까?Review Published on 2022-03-292022-09-11 Journal: Molecules [Category] SARS, 변종, [키워드] abatement acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Can causative agent cause claimed Community coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 pandemic Evidence Hospitalization Human Hybrid immunity Immunity in sight increase in less Mutation natural natural immunity natural immunity. occur omicron Omicron variant Omicron variants pandemic predicted provide reduce Research resulting SARS-CoV-2 severe acute respiratory syndrome Coronavirus sight Spread subsequent surpassed Symptoms the disease the SARS-CoV-2 Transmissibility vaccination variant variants virus while [DOI] 10.3390/molecules27072221 PMC 바로가기 [Article Type] Review
Post–COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patientsOriginal Article Published on 2022-03-232022-10-04 Journal: Clinical microbiology and infection : the official [Category] MERS, SARS, 바이오마커, 진단, [키워드] 95% CI Abstract acute infection association conducted COVID-19 COVID-19 vaccination disease onset domain humoral Humoral response Hybrid immunity IgG Image interquartile range Long COVID-19 median natural immunity natural infection no significant difference objective Occurrence Outpatient Patient patients persistence Post–COVID-19 Post–COVID-19 Prospective Study RBD response to vaccination Result SARS Coronavirus SARS-CoV-2 antibodies SARS-CoV-2 IgG SARS-CoV-2 serology SARS-CoV-2 vaccination serological Serological assay significantly higher Symptom syndrome titre unvaccinated Vaccinated vaccination Vaccination Status with COVID-19 without symptom worsening [DOI] 10.1016/j.cmi.2022.03.016 PMC 바로가기 [Article Type] Original Article